The US Food & Drug Administration approved the EMBLEM S-ICD system in 2012. Boston Scientific promotes the EMBLEM S-ICD as the only subcutaneous implantable cardioverter defibrillator (ICD) that is designed to protect from injuries caused by certain cardiac events or complications with transvenous leads.
Comments are closed.